StockData

Cell Source, Inc. (CLCS) shareholders

CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026Market cap $21.99MP/E –Yield –

Ownership

Who owns Cell Source's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
David Zolty
Director
Jun 30, 2021Other+4,860$0.75$3.65K1,127,504
Darlene Soave
Director, 10% owner
Jun 30, 2021Other+59,507$0.75$44.63K174,434
Dennis M. Brown
Director
Jun 30, 2021Other+2,976$0.75$2.23K114,927
Benzion Abraham Friedman
Director, 10% owner
Jun 30, 2021Other+19,440$0.75$14.58K4,408,184
Benzion Abraham Friedman
Director, 10% owner
Dec 29, 2020Other+19,672$0.75$14.75K4,471,200
David Zolty
Director
Dec 29, 2020Other+4,941$0.75$3.71K1,117,784
Dennis M. Brown
Director
Dec 29, 2020Other+3,025$0.75$2.27K111,951
Benzion Abraham Friedman
Director, 10% owner
Jun 30, 2020Other+19,547$0.75$14.66K4,451,438
David Zolty
Director
Jun 30, 2020Other+4,887$0.75$3.67K1,112,843
Dennis M. Brown
Director
Jun 30, 2020Other+2,992$0.75$2.24K108,926
Benzion Abraham Friedman
Director, 10% owner
Dec 31, 2019Other+25,675$0.75$19.26K4,431,891
David Zolty
Director
Dec 31, 2019Other+6,420$0.75$4.82K1,107,956
Dennis M. Brown
Director
Dec 31, 2019Other+5,934$0.75$4.45K105,934
Benzion Abraham Friedman
Director, 10% owner
Jun 26, 2019Other+5,356$0.75$4.02K4,406,216
David Zolty
Director
Jun 26, 2019Other+1,339$0.75$1.00K1,101,536
Benzion Abraham Friedman
Director, 10% owner
Dec 31, 2018Other+5,444$0.75$4.08K4,400,860
David Zolty
Director
Dec 31, 2018Other+1,361$0.75$1.02K1,100,197
Benzion Abraham Friedman
Director, 10% owner
Aug 21, 2018Other+6,672$0.75$5.00K4,395,416
David Zolty
Director
Aug 21, 2018Other+1,668$0.75$1.25K1,098,836
Benzion Abraham Friedman
Director, 10% owner
Dec 4, 2017Other+5,400$0.75$4.05K4,388,744
David Zolty
Director
Dec 4, 2017Other+1,350$0.75$1.01K1,097,168

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.1
At 0M shares a day
Change since last report
-32.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cell Source's stock actually held short. Settlement fails (shares not delivered on time) peaked at 915 shares on Sep 18, 2026 over the last 90 days.

See a number that looks wrong?